A study on the safety profile and clinical outcomes in patients using tulobuterol transdermal patch as an add on therapy in stable chronic obstructive pulmonary disease

Author:

R Radhika1ORCID,Thomas Beena2,Rafad Ahmed,James Jerin,Chenthiyethu Mekha Monsi,Lal Ruben Thomas

Affiliation:

1. Pushpagiri Institute of Medical Sciences & Research Centre, Thiruvalla, Kerala, India

2. P

Abstract

Tulobuterol Transdermal Drug Delivery (TTD) may be beneficial in COPD management. We aimed to study the effect of adding TTD to Triple Inhalation therapy (TI). Participants on TTD and TI (TTD-TI cohort) and, TI only (TI cohort) were identified at the out-patient pharmacy counter. There was no loss to follow-up from 35 participants each enrolled in the cohorts. They were assessed with Modified British Medical Research Council questionnaire (modified Medical Research Council), COPD Control Questionnaire (CCQ) and COPD Assessment Test (CAT). The latter two were repeated at the end of six months. The change in score were compared with Mann-Whitney-U test. Mean age of participants in years was 63.4 and 65.7; 31% and 20% were females and rest were males in TTD-TI and TI cohorts respectively. All of them had modified Medical Research Council grade 2 or above. CCQ and CAT scores were comparable at baseline. Change in both CCQ and CAT scores were statistically significant between the cohorts (p<0.001). Median (minimum, maximum) change in CCQ score were -0.6(-2.8, 0) in TTD-TI cohort and 0.3(-2 to 1.2) in TI cohort. Median (minimum, maximum) change in CAT score were -4(-16, -2) in TTD-TI cohort and 2(-7 to 7) in TI cohort. All of the participants in TTD-TI cohort and, 5(14.3%) and 7(20%) participants improved in TI cohort by CCQ and CAT score respectively. There would be a subjective improvement with addition of tulobuterol transdermal patch on to triple inhalation therapy for older persons with COPD.

Publisher

IP Innovative Publication Pvt Ltd

Subject

General Materials Science

Reference17 articles.

1. Salvi S, Kumar G A, Dhaliwal R S, Paulson K, Koul K A, The burden of chronic respiratory diseases and their heterogeneity at the states of India; the Global Burden of Disease Study 1990-2016..Lancet Global Health 2018;6(12):1363-74

2. Chronic obstructive pulmonary disease (COPD). Available from URL:- http://www.who.int/news-room/fact-sheets/detail/chronic obstructive-pulmonary-disease-(copd). Last accessed 2021 on October 9..

3. Global Initiative for Chronic Obstructive Lung Disease global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease;2020. Available from URL:- http://www.goldcopd.org/. Last accessed 2021 on October 9..

4. Petite S E, What is the role of triple inhaled therapy in COPD?.JAAPA 2019;32(10):44-5

5. Al-Showair RAM, Tarsin W Y, Assi K H, Pearson S B, Chrystyn H, Can all patients with COPD use the correct inhalation flow with all inhalers and does training help.Respir Med 2007;101(11):2395-401

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3